2MOHRAZ M, SEDAGHAT A, ALINAGHI SA, et al. Post Marketing Surveillance on Safety And Efficacy of IMOD in Iranian patients with HIV/AIDS [ J ]. Infect Disord Drug Targets 2013.
3卫生部.全国艾滋病监测工作规范[S].2002.
4MAHLE GRAY K, TANG T, SHOUSE L, et al. Using the HIV surveillance system to monitor the National HIV/AIDS Strategy [J]. Am J Public Health,2013, 103( 1 ) : 141-7.
5HIV and AIDS surveillance [ R ]. Commun Dis Intell Q Rep, 2012,36(4) : E368.
6HOSSEINIPOUR MC, GUPTA RK, VAN ZYL G, et al. Emergence of HIV Drug Resistance During First-and Second- Line Antiretroviral Therapy in Resource-Limited Settings [ J ]. J Infect Dis,2013,207(2) : $49-56.
7卫生部.疾病预防控制工作绩效考核评估标准[R].卫疾控发[2008]68号.
8FELDMAN BS, KARK JD, ZARKA S, et al. Behavioral surveillance of knowledge about HIV/AIDS transmission and perceived need for additional knowledge in a national sample of young israeli men and women between 1993 and 2005 [ J ]. AIDS Behav ,2011,15 ( 1 ) : 193-203.
